Mylan mondrianaccess state

At Mylan, delivering better health for a better Puerto Rico isn’t our job.
It’s our mission.

Mylan’s roots are in the U.S., and our products can likely be found in most American homes. In 2016 alone, our generics saved the nation’s healthcare system approximately $25 billion. As for manufacturing, a majority of the doses we sell in America are manufactured in America.*

*Manufactured from domestic and imported components.

Better Health for a Better Puerto Rico

Scroll

ACCESS TO MEDICINE

In 2016, Mylan generics saved the U.S.

$25 billion 
We believe everyone deserves the opportunity to live a healthy life, including you. That’s why our business is predicated on providing a sustainable supply of high quality medicine that is accessible, acceptable, available and affordable to patients around the world.
Mylan pig
Scroll

INNOVATION & SCIENCE

Innovation and science are cornerstones of Mylan’s success over the last 50+ years. They will continue to be the foundation of our future.

Mylan has global research centers in the U.S. and India and 10 technology-focused sites around the world.
Scroll

PUBLIC HEALTH & POLICY

Mylan GettyImages

One of the most powerful ways to serve patients in need is by speaking out on their behalf.

We work closely with government, trade associations, healthcare providers, patient advocacy groups and others to shape policy to help people in the U.S. enjoy better health.

Scroll

COMMUNITY IMPACT

In 2017, we provided relief to Mylan employees and the Caguas community at large who were impacted by Hurricane Maria. In addition to providing medicine, we chartered a cargo aircraft to Puerto Rico carrying more than 36,000 pounds of essential items needed by local residents and Mylan employees. We also opened the doors of our plant to Mylan employees and those in the surrounding community to provide food, water and other assistance from the site, in close coordination with local authorities.
Mylan charity state
Scroll

Mylan's School Access Program - PR

Epinephrine is the only first-line treatment for anaphylaxis, a potentially life-threatening allergic reaction. Several years ago, we recognized that epinephrine auto-injectors needed to be as accessible as defibrillators are in public spaces. So Mylan advocated for legislation to permit “undesignated” epinephrine auto-injectors in schools – meaning a prescription could be in a school’s name rather than in a child’s name and any individual experiencing an anaphylactic emergency would have access to the epinephrine auto-injectors. Today, 48 states have adopted such laws, and Mylan has donated nearly 1 million epinephrine auto-injectors to more than 73,000 schools around the country through the school access program.